chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient woke up the following morning with nausea/vomting/diarrhea; sxs started at 6:30 a.m. and resolved by 10 a.m. on the same day.
Hepatocellular carcinoma. Hospital admission within 6 weeks of receiving the COVID vaccine.
Within 24 Hours of injection I developed a severe case of Shingles on Right side of head including Right Eye.  Treatment includes Prednisone, Valtrex, Medicated Eye Drops. Outcome continues.
Vaccine was administered 10/12/20. Had pain immediately. Never went away. 6-7 days after got worse. Prednisone Prescribed 10/20/20. Temporary relief. Got worse again. Prednisone Prescribed again 11/9. XRay done today
Information has been received from a health professional concerning a 17 year old female who on 29-APR-2008 was vaccinated intramuscularly with her first dose of GARDASIL vaccine (yeast) (lot# 0152X). On 29-APR-2008, about 3 hours after vaccination, the patient experienced a rash on her face. The patient was instructed to use over the counter diphenhydramine hydrochloride (BENADRYL) to treat rash. Subsequently, the patient recovered from the rash on her face. The patient sought  unspecified medical attention. Additional information has been requested.
Shortness of breath, anxiety, BP 227/104 (pulse 69), O2 sat 98%. BP eventually went down (not listed in report).
severe chest pain that would come and go every 20-30 minutes in sharp increments; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 at 10:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation.  The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 10:45, 24 hours after receiving the second dose of vaccine, the patient experienced severe chest pain that would come and go every 20-30 minutes in sharp increments. That lasted about 7 to 8 hours. The pain was concentrated in the middle of the patient's chest. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event severe chest pain that would come and go every 20-30 minutes in sharp increments. The clinical outcome of the event severe chest pain that would come and go every 20-30 minutes in sharp increments was resolved on 06Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient described reaction manifested as red circle at the site of injection that is mildly painful and warm to the touch. Patient did not endorse any signs of inflammation, not fever or trouble breathing at any point since onset of reaction.
She had a positive covid test on 16Jan2021. Symptoms on 10Jan2021; She had a positive covid test on 16Jan2021. Symptoms on 10Jan2021; headache; Fatigue; This is a spontaneous report from a contactable Other HCP. A 48-year-old female patient received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EL0142 and Expiration Date unknown) via Intramuscular on 08Jan2021 12:00 PM (vaccine location: Left arm) at single dose for COVID-19 immunisation. Previous vaccine included first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EK5730 and Expiration Date unknown) via Intramuscular on 19Dec2020 11:15 AM (vaccine location: Left arm) at single dose for COVID-19 immunisation and first dose of measles vaccine, mumps vaccine, rubella vaccine (MMR) booster for immunisation. The patient's medical history was included allergies to nubain and CT dye, chronic sinus issues. The concomitant vaccine included second dose of measles vaccine, mumps vaccine, rubella vaccine (MMR) booster on 23Nov2020 for immunisation. Patient had symptoms of increase headache and fatigue on 10Jan2021. Patient had a positive covid test on 16Jan2021. The outcome of events was not recovered and without treatment received.; Sender's Comments: Based on the available information, causality between events Drug ineffective / COVID-19 virus test positive and BNT162B2 vaccine cannot be completely excluded.
M-M-R- II that underwent temperature excursions ABOVE 9°C was administered; No addittional adverse effect reported; This spontaneous report was received from an unspecified reporter from the physician's office referring to an unreported age and gender patient. The patient's pertinent medical history, drug reactions, allergies, and concomitant medication were not reported.   On an unspecified date, the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHa) (M-M-R II) (lot number T033814, expiration date 05-OCT-2022) underwent temperature excursions above 9 degrees Celsius (C) as follows: 12.4 C for 54 minutes (min), 9.6 C for 34 min, 9.5 C for 23 min, and 8.5 C for 9 min (product storage error temperature too high). There was no previous temperature excursion.   On 12-OCT-2021, the patient was administered the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHa) (M-M-R II) that underwent temperature excursions for prophylaxis (formulation, concentration, dose, dose number, vaccination scheme frequency, route of administration, and anatomical location of vaccination were not reported).         No additional adverse effect was reported (no adverse event).  This is one of several reports of patients who were administered the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHa) (M-M-R II) that underwent temperature excursions and were received from the same reporter.; Sender's Comments:  US-009507513-2112USA006870:
Chills, fatigue, temperature high of 104.1, 103.6, 102.7, 100.9, 99.8, for 48 hours.
Right deltoid and part of shoulder with increased swelling, erythematous, warm to touch.  No fever.  Treatment: cold compression, Motrin.
I have multiple Sclerosis which has been well controlled with no exacerbations since 2008. It presents itself as weakness in my left arm and leg. I experience gait impairment. At approximately 36 hours after my first shot, I woke up to use the bathroom and I felt horrible. Neither of my legs worked at all. My left arm was completely limp and my right arm barely functioned. Although these are symptoms associated with my MS they have never been this bad. It was a sudden onset. Prior to the vaccine, I used a cane to help with my balance and gait. However following the vaccine I now must use a walker 100% of the time even in my own home. I have not regained any of the strength that I lost that day. I contacted my neurologist after a few days. The person who took the message told my neurologist that my arm was sore from the shot. Which was incorrect. I had complained that I could neither walk or lift my arm. So the nurse in neurology told me to wait for a couple of days and it would get better. What a mistake that was. A month later I received my second dose and I experienced typical symptoms for 24 hours that would be expected with the second dose and that does not concern me. So on 04/14/2021, I contact my neurologist who is a nurse practitioner and the doctor. They ordered an MRI and treatments of prednisone infusion (three doses of IV prednisone infusion.) Which didn't really help me regain and of my strength. They ordered MRI of my head, cervical spine and thoracic spine. There was a spot on my thoracic spine which had not previously been observed in previous MRI's. Because 90 days had passed since the initial vaccine shot and the MRI, Doctor said they could not say whether or not the vaccine was related to the damage shown in the MRI however it was clear that the vaccine triggered some sort of immune response that adversely affected my multiple sclerosis. Since that time I had and continue to engage in intensive physical therapy and exercise and have had regained about 80% of function compared to my baseline prior to the first vaccine dose. For this reason the doctor said that, should I feel that a booster is not right for me the Medical Center would fully support that decision.
My son, began to suffer from cholinergic urticaria with hives and rash 2 weeks after second dose.  It is likely he had covid in February 2020, but we were not able to have a test that early.  So this would likely have been his third experience with covid:  having the disease, then 2 doses of vaccine.
AFTER FEW DAYS, FELT DISCOMFORT, ESPECIALLY WITH ANY APPLIED PRESSURE TO ARM. OVER NEXT 30-45 DAYS, EXPERIENCED SOME LOSS IN RANGE OF MOTION. IN LAST 2 WEEKS, PAIN PROGRESSED AND RANGE OF MOTION DECREASED MORE. WAS SEEN AND DIAGNOSED WITH BURSITIS. GIVEN A COURSE OF STEROID BLAST AND PAIN MEDICATION. WILL FOLLOW UP WITH DOCTOR PENDING RESULTS.
ACUTE RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Patient parent called child right leg was red and swollen painful to walk, patient was seen the next day by the PA, and was given mupirocin 2% cream.
The patient was admitted to the hospital on 09/11/2001. The patient was running a fever, 104-105F, could not walk, and could not eat. The patient complained of being tired and weak on 08/11/2001. On 08/27/2001 the patient was taken to minor care. The patient was taken to the ER on 08/29/2001 with arthritis and fluid around his heart. Annual follow up received on 2/07/2005 states: "Doctors have told us that they do not know if pt is recovered or if the problems will reoccur - Pt is exempt from vaccine immunizations of Hep B in the future - doctors told us that  and the vaccine was the cause of all his illnesses."
Pt recvd vax on 20SEP92 & following vax pt devel a local reaction & flu sx; 1 wk later devel paresthesia of the fingers which extended to include th ulnar nerve; No further details were provided;
pt recv vax; high pitched cry for 45 mins; no redness/swelling; T 100; MD instructed;
Red patch/rash? raised skin in rectangular shape, approx 2? by 3?, injection site.  Itchy and hot to touch.  Went away after 1 week.
PT had severe swelling and redness around injection site. Pain, tenderness, & erythema. X2 days - treated at facility with Diphenhydramine 50 mg
shortness of breath called 911 around noon admitted to ER around 1pm tests in ER determined Bilateral Pulmonary Embolism Pushed meds to help dissolve clots Intubated to help breath as meds were pushed Passed away before being transferred from ER to ICU around 11:30pm same day
In January 2023 after dose 5 I began to have an erratic heartbeat.  It would stop and start over and over and I was lightheaded.  It lasted for a couple of hours.  I went to the emergency department and was there for about 9 hours and had 3 sets of EKGs.  I was sent home about midnight with a cardiac event monitor that I wore for 30 days.  About a week later my heart began to beat very erratically and went on for quite some time.  I was taken to the emergency department by ambulance.  I was kept for several hours until my symptoms subsided.  After that I saw an arrythmia specialist.  My symptoms have gradually subsided, but I have several follow-up appointments in cardiology.
Blood in urine and rash mid chest following vaccination. Blood in urine lasted for two days. Patient continues to have rash with itchiness on chest up to date.
1983 Pt vax w/ 2nd hepta B; pt devel swelling + pain at inject site and generalized hives,  tx w/ DPH
hot swollen area on the left arm vertical measures 2 1/2 inches and horizontal measures 4 inches  No treatment at this time
I had a clear runny nose and I took two COVID-19 test at home that came back positive. I also took a PCR COVID-19 test that came back positive as well. I called my doctor, and they prescribed me PAXLOVID. I did not develop any other symptoms besides the clear runny nose that lasted for two days.
pt recv vax 23APR96 & 23DEC97 pt exp chickenpox w/approx 40 lesions;
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: patient called on 10/5/22 and said she received her flu vaccine on 9/28/22 and on 10/03/22, her arm below the injection site was red, inflamed, and itchy. She is out of town but I told her to keep an eye on it and see a doctor if it did not improve. not sure if its vaccine related, but patient was concerned so i recommended she see a doctor to get it checked out
Had anaphylaxis immediately after flu vaccine in 2019; This case was reported by a physician via sales rep and described the occurrence of anaphylaxis in a female patient who received Flu Seasonal QIV Dresden (Fluarix Tetra) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of no adverse event (never had an issue).   On an unknown date, the patient received Fluarix Tetra. On an unknown date, immediately after receiving Fluarix Tetra, the patient experienced anaphylaxis (serious criteria GSK medically significant). On an unknown date, the outcome of the anaphylaxis was recovered/resolved.   It was unknown if the reporter considered the anaphylaxis to be related to Fluarix Tetra.  Additional details were reported as follows: The age at vaccination was not reported. In 2019, the patient received Fluarix vaccine 2019 and had an anaphylaxis immediately. In 2020, the patient received FluLaval Quadrivalent 2020. The patient saw allergist who performed allergy testing on 2020 Flu. The reported asked that someone from vaccine division could tell what might be causing the Anaphylaxis. It was unknown if reporter consent to follow-up.
Since the vaccine, I have been diagnosed with Lupus SLE and Raynaud's Disease.  I have been in the ER for head and neck weakness, tremors, and fatigue.  My second visit to the hospital ended up in a 4 day stay.  Every day of my life is a struggle now.  I am on 4 different medications to treat my day to day lupus.  I am unable to be in the sun due to my sensitive skin issues.  My life has been turned upside down.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 68-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included stem cell transplant. Concomitant products included acyclovir.  On 6th June 2018, the patient received the 1st dose of SHINGRIX. In July 2018, less than a year after receiving SHINGRIX, the patient experienced shingles, numbness and tingling. On an unknown date, the outcome of the shingles, numbness and tingling were unknown. It was unknown if the reporter considered the shingles, numbness and tingling to be related to SHINGRIX. Additional details were provided as follows: The patient did not specify why acyclovir was being taken or for what the stem cell transplant was for. The patient stopped acyclovir the day after her SHINGRIX injection, by doctor's order. The patient reported that during the last week in July 2018, she experienced shingles, primarily on the lower back and abdomen, near the navel. The patient reported that the shingles also consisted of some numbness and tingling. The patient had denied permission to contact their physician.
REALLY SEVERE BODY PAIN; VACCINE KICKED MY BUTT; ENCOUNTERED EVERY SINGLE SIDE EFFECT LISTED BY J&J; NEVER HONESTLY FELT SO SICK IN MY LIFE; 102 TEMPERATURE FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on AUG-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On AUG-2021, the patient experienced really severe body pain. On AUG-2021, the patient experienced vaccine kicked my butt. On AUG-2021, the patient experienced encountered every single side effect listed by j&j. On AUG-2021, the patient experienced never honestly felt so sick in my life. On AUG-2021, the patient experienced 102 temperature fever. Laboratory data included: Body temperature (NR: not provided) 102. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from never honestly felt so sick in my life, 102 temperature fever, really severe body pain, vaccine kicked my butt, and encountered every single side effect listed by j&j. This report was non-serious.
Patient has history of MS well controlled with Cosentix injections. Patient reports approximately one week after taking vaccine he began experiencing pain in his feet and ankles. Reports the pain has ascended to lower back and reports he can no longer lift heavy objects and cannot perform required duties for his occupation. Denies numbness, tingling, burning. Difficulty with walking, especially distances or stairs. Reports pervasive fatigue and sleeping until late in the day but waking up exhausted.
On 5/9/00, the pt experienced varicella, early cellutitis, the pt was treated with Bactroban.
I'm sick and need to reschedule.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: solution for injection, Lot number: not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient reported that I was sick and need to reschedule on an unspecified date. The outcome of the event was unknown.
pt. was given pfizer first dose for ages 5-12 years of age instead of pfizer first dose for ages 6 months to 4 years of age.
co-worker noticed rt arm was very red on Sat PM approx 2 cm; stated arm was very sore; redness cont down arm & devel knot on inner forearm approx 1 cm; arm was very hot to the touch & was painful even up into neck & shoulder;
Information has been received from a mother concerning her daughter with pertinent medical history, allergies and concomitant medication not reported who approximately 15-MAR-2008 (two months ago) was vaccinated with a dose of GARDASIL and hasn't had her period since. The outcome and causality of the event was not reported. Additional information is not expected.
Numb tongue and lips; Rash all over; This spontaneous case was retrieved on 03-Oct-2023 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2683063-1) reported by other healthcare professional and concerned a 42-year-old, female patient.    The patient's medical history and concomitant medications were not reported. The patient had no other known allergies.  It was reported that on 07-Sep-2023, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine inact split 4v; dose reported as '1', route of administration: intramuscular, anatomical location: right arm (RA), and indication: not reported). The batch number reported was 370651. The reported batch number was identified by Seqirus to be linked to the suspect product Flucelvax Quadrivalent (influenza vaccine inact sag 4v) instead of the reported suspect product Afluria Quadrivalent. Based on the reported batch number, the suspect product was changed to Flucelvax Quadrivalent vaccine.  On the same date (discrepancy reported as 18-Sep-2023), after receiving Flucelvax Quadrivalent, the patient experienced numb tongue and lips. Soon after, the patient experienced a rash all over. The patient was seen at an emergency room (ER). The patient had taken Benadryl (diphenhydramine hydrochloride) at the recommendation of a nurse practitioner (NP). As reported, the patient was going to see an allergy doctor.  On an unspecified date in Sep-2023, the patient recovered from both events.  The reporter did not provide a causality assessment.   The events of 'hypoaesthesia oral' and  rash all over were considered to be medically significant by a Physician within CSL Seqirus' Pharmacovigilance Department.  Company comment: On the same date, after receiving Flucelvax Quadrivalent, the patient experienced numb tongue and lips, as well as rash. The patient was seen at an emergency room (ER) and had taken Benadryl. The patient recovered from both events. Causal role of influenza vaccine is assessed as possibly related for rash and hypoesthesia oral, due to suggestive chronology.; Sender's Comments: On the same date, after receiving Flucelvax Quadrivalent, the patient experienced numb tongue and lips, as well as rash. The patient was seen at an emergency room (ER) and had taken Benadryl. The patient recovered from both events. Causal role of influenza vaccine is assessed as possibly related for rash and hypoesthesia oral, due to suggestive chronology.
Dizziness, headache, nausea, BP 86/55, pulse 58, O2Sat 96%  Paramedics called and observed for 15 mins.
Palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Palpitations). At the time of the report, PALPITATIONS (Palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment information were not reported.  The reporter did not know if it was Moderna or Pfizer vaccine. Company Comment: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Breakthrough case admission after 3 vaccines Pfizer 1/18/21 Lot# EL3249;  Pfizer 2/8/21 Lot# El9265;  Pfizer 10/14/21 Lot# FE3590
developed rash and hives 04/07. never had either historically. as of 05/02 hives and daily rash like symptoms still present although more bearable.
swelling right foot (toe and bottom of foot); Swollen arm; a lot of pain in right foot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a lot of pain in right foot), PERIPHERAL SWELLING (swelling right foot (toe and bottom of foot)) and PERIPHERAL SWELLING (Swollen arm) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (a lot of pain in right foot) and PERIPHERAL SWELLING (Swollen arm). On 25-Mar-2021, the patient experienced PERIPHERAL SWELLING (swelling right foot (toe and bottom of foot)). At the time of the report, PAIN IN EXTREMITY (a lot of pain in right foot), PERIPHERAL SWELLING (swelling right foot (toe and bottom of foot)) and PERIPHERAL SWELLING (Swollen arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment medications was not given.